Giving the Thrombosis and Hemostasis Community a Voice to Drive Prioritisation

The European Thrombosis and Haemostasis Alliance (ETHA) has 28 member organizations within the European Union. If you would like to join this important cause of increasing the share of voice and driving prioritisation of thrombosis ...
Header image

What is the European Thrombosis and Haemostasis Alliance?

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 28 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

ETHA has come together to give the European thrombosis and hemostasis community an allied voice and to provide input to EU health and patient safety strategies, make recommendations on EU research programme funding and encourage sharing and adoption of best practices in the treatment and prevention of thrombotic and bleeding disorders.

To learn more about ETHA’s initial areas of priority, read its consensus statement, here.

News

Statement from the International Society on Thrombosis and H...

Earlier this week, the European Medicines Agency (EMA) and UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) completed their assessments of extremely rare blood clotting events associated with low platelet counts tha...

Continue reading

European Thrombosis and Haemostasis Alliance Welcomes Europe...

18 March 2021 – The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the European Medicines Agency’s (EMA) decision today following the recent reports of thrombotic events (blood clots) following COVID-19 vaccina...

Continue reading